We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jeffrey Jones

Jeffrey A. Jones MD

Jeffrey Jones, MD, is an assistant professor of hematology at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute in Columbus, Ohio, where he specialized in the treatment of chronic lymphocytic leukemia, non-Hodkin’s lymphoma, lymphoma and Hairy Cell leukemia. A clinican-scienist, he also part of a robust leukemia research at The OSUCCC – James focused on translational therapeutics. He received his medical degree at the University of Michigan, followed by a residency at McGill University and fellowship at MD Anderson Cancer Center.  

Recent Contributions to PracticeUpdate:

  1. Ibrutinib Prolongs Progression-Free Survival in CLL